Research Article
The Role of Symptom Duration and Serologic Factors in the Relapse of IgG4-Related Ophthalmic Disease following Surgery: A Retrospective Cohort Study
Table 2
Baseline clinical characteristics of patients in the short- and long-duration groups.
| Variables | Short symptom duration | Long symptom duration | value | Variables | Short symptom duration | Long symptom duration | value |
| Gender | | | 0.397 | Lacrimal glands | | | 0.305 | Male | 19 (73.1%) | 9 (90.0%) | | Yes | 24 (92.3%) | 8 (80.0%) | | Female | 7 (26.9%) | 1 (10.0%) | | No | 2 (7.7%) | 2 (20.0%) | | Laterality | | | 0.270 | Extraocular muscles | | | 0.462 | Unilateral | 11 (42.3%) | 2 (20.0%) | | Yes | 9 (34.6%) | 5 (50.0%) | | Bilateral | 15 (57.7%) | 8 (80.0%) | | No | 17 (65.4%) | 5 (50.0%) | | Smoking history | | | 0.179 | Orbital fat | | | 0.057 | Yes | 4 (15.4%) | 4 (40.0%) | | Yes | 1 (3.9%) | 3 (30.0%) | | No | 22 (84.6%) | 6 (60.0%) | | No | 25 (96.2%) | 7 (70.0%) | | Diplopia | | | 0.686 | Optic nerve | | | 0.181 | Yes | 6 (23.1%) | 3 (30.0%) | | Yes | 1 (3.9%) | 2 (20.0%) | | No | 20 (76.9%) | 7 (70.0%) | | No | 25 (96.2%) | 8 (80.0%) | | Eyelid hyperemia | | | 1.000 | Trigeminal nerve | | | 0.226 | Yes | 9 (34.6%) | 4 (40.0%) | | Yes | 5 (19.2%) | 4 (40.0%) | | No | 17 (65.4%) | 6 (60.0%) | | No | 21 (80.8%) | 6 (60.0%) | | Decreased vision | | | 0.057 | Paranasal sinusitis | | | 0.397 | Yes | 1 (3.9%) | 3 (30.0%) | | Yes | 19 (73.1%) | 9 (90.0%) | | No | 25 (96.2%) | 7 (70.0%) | | No | 7 (26.9%) | 1 (10.0%) | | Eyelid swelling | | | 0.076 | Asthma | | | 0.018 | Yes | 18 (69.2%) | 10 (100.0%) | | Yes | 6 (23.1%) | 7 (70.0%) | | No | 8 (30.8%) | 0 (0.0%) | | No | 20 (76.9%) | 3 (30.0%) | | Exophthalmia | | | 0.274 | Recurrence | | | 0.026 | Yes | 12 (46.2%) | 7 (70.0%) | | Yes | 7 (26.9%) | 7 (70.0%) | | No | 14 (53.9%) | 3 (30.0%) | No | 19 (73.1%) | 3 (30.0%) | |
|
|
aContinuous correction chi-square test. bFisher exact test.
|